OakChart

Precipio Inc

PRPOHealthcare·Diagnostics & Research·USA·Nano·NASD·Nov 10 • 3:59 PM ET

23.650.00 (0.00%)
2026-11-11 15:13 CET
Market cap
42.34 USD m
Revenue, TTM
27.76 USD m
Net income, TTM
-1.14 USD m
Free cash flow, TTM
1.39 USD m
EPS diluted, TTM
-0.64
P/E
-
Compare

Price

PRPO against its 20, 50 and 200-day averages
2050200
20.0025.0030.00212K424KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PRPOclose 23.6520-day 20.2550-day 23.19200-day 24.8323.65

29.7% under 33.63 on 6 May 2026. Last 15 sessions, 34.3% high to low

Profile

PRPO
52-week range, 37% of the way up
17.7933.63

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Employees61
IPOJul 18, 2000
Beta1.39
ATR, 14d1.50
Rel volume0.00
Short float3.50%
Insider own12.57%
Inst own17.14%

Snapshot

6 groups

Valuation

Index-
Market Cap42.34M
Enterprise Value42.45M
Income-1.14M
Sales27.76M
Book/sh8.29
Cash/sh2.00
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees61
IPOJul 18, 2000

Ratios

P/E-
Forward P/E-
PEG-
P/S1.53
P/B2.85
P/C11.83
P/FCF30.46
EV/EBITDA103.54
EV/Sales1.53
Quick Ratio1.54
Current Ratio1.77
Debt/Eq0.25
LT Debt/Eq0.19
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.64
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y72.37% 57.83%
Sales past 3/5Y36.71% 31.60%
EPS Y/Y TTM43.26%
Sales Y/Y TTM21.76%
EPS Q/Q90.66%
Sales Q/Q8.33%
EarningsNov 10 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own12.57%
Insider Trans-1.76%
Inst Own17.14%
Inst Trans0.96%
ROA-5.34%
ROE-8.00%
ROIC-6.45%
Gross Margin37.74%
Oper. Margin-5.34%
Profit Margin-4.12%
SMA2016.77%
SMA501.98%
SMA200-4.76%
Trades-

Technical

Shs Outstand1.79M
Shs Float1.57M
Short Float3.50%
Short Ratio0.56
Short Interest0.05M
52W High33.63 -29.68%
52W Low17.79 32.94%
Volatility10.52% 6.36%
ATR (14)1.50
RSI (14)61.71
Beta1.39
Rel Volume0.00
Avg Volume98.38K
Volume0

Performance

Perf Week27.01%
Perf Month4.69%
Perf Quarter4.92%
Perf Half Y-17.54%
Perf YTD2.92%
Perf Year16.85%
Perf 3Y188.86%
Perf 5Y-46.25%
Perf 10Y-98.71%
Recom1.00
Target Price19.00
Prev Close23.65
Price23.65
Change %0.00%

Peers

Mkt cap
TickerCompanyMkt cap
NEONeogenomics Inc2.21B
MDXHMDxHealth SA13.57M
QGENQiagen NV10.38B
BNGOBionano Genomics Inc16.77M
IMDXInsight Molecular Diagnostics Inc80.83M
BDSXBiodesix Inc105.90M
XGNExagen Inc135.29M
VCYTVeracyte Inc1.98B
CSTLCastle Biosciences Inc1.06B
PSNLPersonalis Inc1.72B

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
SANDBERG RICHARD ADirectorMay 21 '26Sale25.0290022,5173,000May 26 04:00 PM
SANDBERG RICHARD ADirectorMay 20 '26Sale24.892,03450,6328,142May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 19 '26Sale24.4260014,6524,400May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 20 '26Sale25.0050012,5003,900May 21 04:00 PM
SANDBERG RICHARD ADirectorMay 19 '26Proposed Sale24.854,034100,245May 19 02:19 PM
Sabet Ahmed ZakiChief Operating OfficerApr 01 '26Buy27.93195311,034Apr 10 04:00 PM
Sabet Ahmed ZakiChief Operating OfficerJan 02 '26Buy23.4020468735Jan 06 04:34 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
DFASU.S. Small Cap Portfolio-ETF Class Shares-
DFSUDimensional US Sustainability Core 1 ETF-
DCORUS Core Equity 1 Portfolio ETF Class Shares-
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
DXUVUS Vector Equity Portfolio ETF Class Shares-

News

latest 14 of 206
  • Precipio Announces Q3-2026 Financial Results (GlobeNewswire) +6.53%
  • Precipio Announces Q3-2026 Shareholder Update Call (InvestorsHub)
  • Precipio Announces Q3-2026 Shareholder Update Call (GlobeNewswire)
  • Top Research Reports for Goldman Sachs, RTX & Abbott (Zacks) +5.12%
  • Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ... (GuruFocus.com) +5.67%
  • Loading…
  • Precipio Announces Q2-2026 Financial Results (GlobeNewswire)
  • Precipio Announces Q2-2026 Shareholder Update Call (GlobeNewswire)
  • Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
  • Precipio to Present at the Planet MicroCap Las Vegas (GlobeNewswire)
  • Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges (GuruFocus.com)
  • Precipio Announces Q1 2026 Financial Results (GlobeNewswire) -8.95%
  • Management team's 2025 market-based Options have vested (GlobeNewswire)
  • B2i Digital Welcomes Precipio, Inc. as a New Featured Company (NewMediaWire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2025Q42026-02-27--0.2956.70--
2025Q32025-11-14-0.050--0.0486.77--
2025Q12025-05-15---0.5884.90--
2024Q32024-11-07-0.420--0.4235.21--
2024Q22024-08-13-0.830--0.8344.444.40-
2023Q32023-11-14-1.040-1.210-1.0434.524.401
2023Q22023-08-01-1.880-2.000-1.8823.502.801
2023Q12023-05-16-2.600-2.600-2.6112.820.761
2022Q42023-03-30-2.800-2.800-2.0072.002.001
2022Q32022-11-14-2.800-0.800-2.7932.225.001
2022Q22022-08-24-1.800-1.800-1.8882.362.361
2022Q12022-08-16-4.000--4.0432.45-1
2021Q42022-04-04-1.400-1.400-1.9423.203.201
2021Q32021-11-15-1.600--1.6382.25--
2021Q22021-08-23-2.800-2.000-2.8642.343.251
2021Q12021-05-20-2.000-2.000-1.6261.681.68-

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2011FY-23,760-10,800-23,76031.9731.99
2012FY-14,040-15,120-14,04031.4830.38
2013FY-1,710--1,71027.54-
2014FY-18,090--18,09027.08-
2019FY-46.600-31.700-46.5063.134.24
2020FY-17.000--16.9566.10-
2021FY-0.370--8.0869.61-
2022FY-10.800--10.8009.41-
2023FY--6.250-4.51015.2015.20

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2024-03-241008.018.018.01
2024Q4S2024-03-231008.018.018.01
2024Q4S2024-03-221008.018.018.01
2024Q4S2024-03-211008.018.018.01
2024Q4S2024-03-201008.018.018.01
2024Q4S2024-03-191008.018.018.01
2024Q4S2024-03-181008.018.018.01
2024Q4S2024-03-171008.018.018.01
2024Q4S2024-03-161008.018.018.01
2024Q4S2024-03-151008.018.018.01
2024Q4S2024-03-141008.018.018.01
2024Q4S2024-03-131008.018.018.01
2024Q4S2024-03-121008.018.018.01
2024Q4S2024-03-111008.018.018.01

Estimate history

EPS, annual-2148-276.396-46.506-16.956-8.086-10.727-4.51-2.927-0.226-0.6409
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.423-0.244-0.5880.046-0.0480.295-0.809-0.123-0.005
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1.7232.8643.1276.0928.8499.41215.19718.53224.04927.76
Period201720182019202020212022202320242025TTM
Sales, quarterly5.2095.454.9295.6546.7676.6996.7117.0217.331
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.0340.1150.3950.8791.1351.1411.421.4941.7811.793
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.4821.4941.5041.5161.7461.7811.7841.7891.793
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue27.7624.0518.5315.209.418.856.093.132.86
Cost of Goods Sold Incl. D&A17.2915.1012.4910.706.906.464.942.912.64
Gross Profit10.488.956.054.502.512.391.150.220.23
Selling, General and Administrative Excl. Other11.9610.1610.2612.1215.3112.0110.309.629.45
Research and Development-1.601.301.701.701.301.201.201.10
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-1.48-1.20-4.22-7.62-12.80-9.61-9.15-9.40-9.23
Interest Expense0.050.070.070.020.010.020.470.470.27
Unusual Expense-0.39-0.140.00-1.72-0.63-1.121.141.574.76
Net Income Before Taxes-1.14-0.36-4.29-5.85-12.18-8.52-10.60-13.31-15.97
Income Taxes0.000.000.000.000.000.000.00-0.07-0.28
Consolidated Net Income-1.14-0.36-4.29-5.85-12.18-8.52-10.60-13.24-15.69
Net Income From Continuing Operations-1.14-0.36-4.29-5.85-12.20-8.53-10.62-13.24-15.69
Net Income-1.14-0.36-4.29-5.85-12.20-8.53-13.97-13.24-19.92
EPS (Recurring)-0.79-0.29-2.93-5.44-11.12-8.83-15.99-42.66-230.12
EPS (Basic, Before Extraordinaries)-0.64-0.23-2.93-4.51-10.73-8.09-16.96-46.51-276.40
EPS (Diluted)-0.64-0.23-2.93-4.51-10.73-8.09-16.96-46.51-276.40
EBITDA0.410.55-2.70-6.10-11.28-8.17-7.79-8.05-7.96
Non-Operating Income (Expense)0.000.770.000.070.000.000.15-1.87-1.71
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.931.211.491.563.801.880.700.490.40
Price To Sales Ratio-1.530.440.561.333.775.603.731.16
Gross Margin37.7437.2332.6229.6226.6727.0318.887.007.86
Operating Margin-5.34-5.00-22.75-50.14-135.96-108.63-150.13-300.74-322.17
Net Margin-4.12-1.51-23.15-38.51-129.65-96.40-229.30-423.50-695.39
Shares Outstanding1.791.781.491.421.141.140.880.390.11
Market Capitalization42.3442.348.219.2312.5835.8836.3816.195.31

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue7.337.026.716.706.775.654.935.45
Cost of Goods Sold Incl. D&A4.454.354.444.044.203.653.213.25
Gross Profit2.892.672.272.662.572.011.722.20
Selling, General and Administrative Excl. Other2.883.273.702.112.632.832.582.65
Other Operating Expense0.000.000.000.000.000.000.00-0.12
Operating Income0.00-0.60-1.430.54-0.06-0.82-0.86-0.34
Interest Expense0.010.010.010.020.010.020.030.03
Unusual Expense0.00-0.390.000.000.00-0.140.000.00
Net Income Before Taxes-0.01-0.22-1.440.53-0.080.07-0.88-0.36
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-0.01-0.22-1.440.53-0.080.07-0.88-0.36
Net Income From Continuing Operations-0.01-0.22-1.440.53-0.080.07-0.88-0.36
Net Income-0.01-0.22-1.440.53-0.080.07-0.88-0.36
EPS (Recurring)-0.00-0.27-0.810.30-0.05-0.02-0.59-0.24
EPS (Basic, Before Extraordinaries)-0.00-0.12-0.810.30-0.050.05-0.59-0.24
EPS (Diluted)-0.00-0.12-0.810.30-0.050.05-0.59-0.24
EBITDA0.49-0.13-0.971.020.38-0.40-0.440.11
Non-Operating Income (Expense)0.000.000.000.00-0.010.780.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.070.770.990.100.230.450.420.44
Price To Sales Ratio-1.631.731.701.280.830.470.45
Gross Margin39.3737.9933.8039.6537.9535.5034.9640.33
Operating Margin0.03-8.53-21.288.09-0.90-14.57-17.43-6.17
Net Margin-0.11-3.12-21.507.85-1.171.31-17.93-6.70
Shares Outstanding1.791.791.781.781.751.521.501.49
Market Capitalization42.3444.2643.8040.2628.8116.699.298.21

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2.651.391.503.4411.672.660.850.380.42
Short Term Receivables1.980.801.301.040.700.970.670.990.83
Inventories0.940.720.380.710.560.350.180.200.16
Other Current Assets0.470.540.490.520.550.220.170.230.33
Total Current Assets6.043.453.685.7113.484.201.881.791.74
Net Property, Plant & Equipment4.291.631.521.902.060.790.950.500.35
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets10.9211.8712.8213.7714.7215.6716.6619.2925.14
Other Assets0.070.040.080.130.180.060.030.030.02
Total Assets21.3217.0018.1021.5030.4420.7119.5121.6127.26
Short Term Debt Incl. Current Port. of LT Debt0.650.620.580.620.410.920.724.700.64
Accounts Payable1.130.620.622.041.861.691.945.175.10
Other Current Liabilities1.973.031.931.701.942.041.673.904.30
Total Current Liabilities3.754.273.144.364.214.664.3313.7710.04
Long Term Debt3.000.630.530.781.020.570.630.412.94
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-------0.07-
Other Liabilities0.000.000.000.000.611.321.341.241.26
Total Liabilities6.764.903.675.145.836.556.3115.4814.23
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity14.5612.0914.4316.3024.5614.1313.216.1213.03
Total Shareholders Equity14.5612.0914.4316.3024.5614.1313.216.1213.03
Accumulated Minority Interest0.000.000.000.070.040.030.000.000.00
Total Equity14.5612.0914.4316.3724.6014.1613.216.1213.03
Total Liabilities & Stockholders Equity21.3217.0018.1021.5030.4420.7119.5121.6127.26
Book Value Per Share8.188.1010.1614.2921.6316.0833.4453.27383.22
Tangible Book Value Per Share2.050.151.132.228.67-1.74-8.74-114.57-356.53
Full-Time Employees616057555557514533
Price to Book Ratio2.870.690.690.691.462.571.230.870.56
Return on Assets-1.89-24.45-29.56-46.99-33.35-52.83-64.42-64.23-145.12
Return on Equity-2.72-32.35-38.09-59.72-44.08-77.72-137.03-163.92-
Return on Invested Capital-2.07-33.71-39.12-71.45-33.35-72.25-95.69-240.30-129.60
Quick Ratio1.360.641.051.153.070.830.390.120.16
Current Ratio1.610.811.171.313.200.900.430.130.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-1.14-0.36-4.29-5.85-12.18-8.52-10.60-39.73-15.69
Depreciation1.891.751.511.521.521.441.361.411.26
Other Funds (Non Cash)2.541.471.950.173.580.893.4431.677.57
Funds from Operations3.292.85-0.83-4.17-7.08-6.18-5.80-6.65-6.86
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-1.59-2.171.270.61-0.64-0.40-1.63-2.490.11
Cash from Operating Activities1.700.690.44-3.56-7.72-6.58-7.43-9.14-6.75
Capital Expenditures-0.31-0.33-0.22-0.13-0.28-0.68-0.15-0.06-0.10
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.060.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.31-0.33-0.22-0.13-0.28-0.68-0.10-0.06-0.10
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.151.380.082.250.1416.618.938.203.28
Repurchase of Common Pref Stock-0.030.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.181.380.082.250.1416.618.938.203.28
Proceedsfrom Stock Options0.000.000.082.250.1316.218.936.632.01
Issuance or Reduction of Debt, Net-0.27-0.48-0.41-0.50-0.36-0.170.411.463.53
Change in Long Term Debt-0.27-0.48-0.41-0.50-0.36-0.170.411.463.53
Issuance of Long Term Debt0.000.000.250.000.000.000.792.034.01
Reduction of Long Term Debt-0.27-0.48-0.66-0.50-0.36-0.17-0.38-0.57-0.48
Net Financing Active Other Cash Flow0.000.000.000.000.00-0.170.00-0.000.00
Other Financing Activities Uses0.000.000.000.000.00-0.170.00-0.000.00
Cash from Financing Activities-0.120.90-0.331.74-0.2316.279.349.666.81
Net Change in Cash1.271.26-0.11-1.94-8.229.011.810.47-0.04
Free Cash Flow1.390.360.22-3.69-8.00-7.26-7.58-9.20-6.85
Preferred Dividends (Cash Flow)-0.000.000.000.000.00-0.00-
Price to Free Cash Flow-102.7437.59------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3.583.082.602.652.311.13
Short Term Receivables2.052.281.991.981.961.49
Inventories0.910.780.870.940.791.06
Other Current Assets0.510.410.470.470.620.38
Total Current Assets7.056.545.936.045.674.05
Net Property, Plant & Equipment4.404.294.124.294.263.31
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets10.2110.4410.6810.9211.1611.39
Other Assets0.060.050.070.070.070.06
Total Assets21.7121.3220.8021.3221.1518.82
Short Term Debt Incl. Current Port. of LT Debt0.830.730.670.650.610.44
Accounts Payable1.240.971.361.131.141.16
Other Current Liabilities1.912.001.781.972.702.75
Total Current Liabilities3.983.703.813.754.454.35
Long Term Debt2.862.862.833.002.952.17
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities6.856.566.646.767.406.53
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity14.8714.7614.1714.5613.7512.29
Total Shareholders Equity14.8714.7614.1714.5613.7512.29
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity14.8714.7614.1714.5613.7512.29
Total Liabilities & Stockholders Equity21.7121.3220.8021.3221.1518.82
Book Value Per Share8.298.257.948.187.888.10
Tangible Book Value Per Share2.602.411.952.051.480.59
Full-Time Employees---61--
Price to Book Ratio2.873.123.062.922.201.42
Return on Assets-5.34-6.05-4.78-1.89-6.58-9.97
Return on Equity-8.00-8.98-7.13-2.72-9.76-14.76
Return on Invested Capital-0.05-1.24-8.492.99-0.470.51
Quick Ratio1.541.561.331.361.100.69
Current Ratio1.771.771.561.611.270.93

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.01-0.22-1.440.53-0.080.07
Depreciation0.490.470.460.480.440.42
Other Funds (Non Cash)0.150.801.300.290.380.36
Funds from Operations0.641.050.311.290.740.85
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.03-0.39-0.25-0.93-0.73-0.50
Cash from Operating Activities0.610.660.060.370.010.35
Capital Expenditures-0.06-0.13-0.05-0.07-0.05-0.06
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.06-0.13-0.05-0.07-0.05-0.06
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.020.010.000.121.260.00
Repurchase of Common Pref Stock0.00-0.030.000.000.000.00
Sale of Common Pref Stock0.020.040.000.121.260.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.07-0.07-0.06-0.07-0.04-0.18
Change in Long Term Debt-0.07-0.07-0.06-0.07-0.04-0.18
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.07-0.07-0.06-0.07-0.04-0.18
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.05-0.06-0.060.061.22-0.18
Net Change in Cash0.500.47-0.050.351.180.11
Free Cash Flow0.550.530.010.29-0.040.29
Price to Free Cash Flow-56.0980.32114.0049.4631.31

Revenue breakdown

Consolidation, Policy2024: 44.00K 2025: 197.00K
Product2024: 2.61M 2025: 2.74M
Service revenue, net2024: 15.92M 2025: 21.31M
United States2024: 18.58M 2025: 24.25M
Consolidation, Policy2024: 44.00K 2025: 197.00K
Single Reportable2024: 18.53M 2025: 24.05M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.50%0.1M1.6M104.28K
2026-10-153.75%0.1M1.6M119.73K
2026-09-304.37%0.1M1.6M128.09K
2026-09-154.70%0.1M1.6M116.27K
2026-08-313.91%0.1M1.6M89.48K
2026-08-143.30%0.1M1.6M70.97K
2026-07-312.38%0.0M1.6M58.09K
2026-07-151.69%0.0M1.6M42.68K
2026-06-301.76%0.0M1.6M34.31K
2026-06-151.21%0.0M1.6M32.98K
2026-05-290.80%0.0M1.6M31.72K
2026-05-150.89%0.0M1.6M29.54K
2026-04-300.43%0.0M1.6M26.92K
2026-04-150.55%0.0M1.6M22.07K
2026-03-310.37%0.0M1.6M17.63K
2026-03-130.38%0.0M1.6M14.17K
2026-02-270.22%0.0M1.6M12.18K
2026-02-130.24%0.0M1.6M12.12K
2026-01-300.27%0.0M1.5M10.33K
2026-01-150.22%0.0M1.5M11.26K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-318-KCurrent report2026-07-31SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-06-158-KCurrent report2026-06-15SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-19144Filing for proposed sale of securities under Rule 144.SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-104Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-03-3010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-278-KCurrent report2026-02-25SEC
2026-02-10SCHEDULE 13G/ASEC
2026-01-26S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-01-204/A2025-10-15SEC
2026-01-204/A2025-10-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500100.30K4
2026-04531100
2026-030000
2026-020000
2026-01468100
2025-120000
2025-110000

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC2.58%
BlackRock, Inc.1.94%
GEODE CAPITAL MANAGEMENT, LLC0.96%
RENAISSANCE TECHNOLOGIES LLC0.91%
CITADEL ADVISORS LLC0.82%
UBS Group AG0.55%
XTX Topco Ltd0.53%
VANGUARD FIDUCIARY TRUST CO0.53%
DIMENSIONAL FUND ADVISORS LP0.47%
WELLS FARGO & COMPANY/MN0.00%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.59%
VANGUARD EXTENDED MARKET INDEX FUND0.99%
Fidelity Extended Market Index Fund0.46%
iShares Micro-Cap ETF0.30%
Fidelity Total Market Index Fund0.18%
Fidelity Nasdaq Composite Index Fund0.17%
U.S. MICRO CAP PORTFOLIO0.15%
Fidelity Series Total Market Index Fund0.13%
Dimensional U.S. Small Cap ETF0.07%
Dimensional US Sustainability Core 1 ETF0.06%

OakChart. PRPO. Cached 15 minutes.

Some panels did not load: ratings.